[1]
Almeida, L.F.C. de et al. 2026. Metronomic versus standard fixed dosing chemotherapy in human epidermal growth factor receptor-type 2-negative metastatic breast cancer: a reconstructed individual patient data meta-analysis. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1010.